Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal By: TalkMarkets July 27, 2024 at 14:40 PM EDT Triastek will develop oral RNA therapeutics with Germany’s BioNTech based on its 3D printing technology. Triastek will receive a $10 million upfront payment and up to $1.2 billion in milestones, plus royalties. Read More >> Related Stocks: Aligos Therapeutics Inc Artiva Biotherapeutics, Inc. - Common Stock Beigene Ltd ADR Biontech Se ADR Eli Lilly Innovent Biologics Inc Travere Therapeutics Inc Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal By: TalkMarkets July 27, 2024 at 14:40 PM EDT Triastek will develop oral RNA therapeutics with Germany’s BioNTech based on its 3D printing technology. Triastek will receive a $10 million upfront payment and up to $1.2 billion in milestones, plus royalties. Read More >> Related Stocks: Aligos Therapeutics Inc Artiva Biotherapeutics, Inc. - Common Stock Beigene Ltd ADR Biontech Se ADR Eli Lilly Innovent Biologics Inc Travere Therapeutics Inc